Loring Wolcott & Coolidge Fiduciary Advisors’s Xerox XRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12
Closed -$222 594
2023
Q4
$222 Hold
12
﹤0.01% 548
2023
Q3
$162 Sell
12
-341
-97% -$5.39K ﹤0.01% 602
2023
Q2
$5.26K Hold
353
﹤0.01% 572
2023
Q1
$5.44K Hold
353
﹤0.01% 544
2022
Q4
$5.15K Sell
353
-298
-46% -$4.49K ﹤0.01% 533
2022
Q3
$9K Hold
651
﹤0.01% 532
2022
Q2
$10K Hold
651
﹤0.01% 550
2022
Q1
$13K Hold
651
﹤0.01% 543
2021
Q4
$15K Buy
651
+298
+84% +$6.05K ﹤0.01% 567
2021
Q3
$7K Buy
353
+341
+2,842% +$7.74K ﹤0.01% 636
2021
Q2
$0 Buy
+12
New +$290 ﹤0.01% 954
2021
Q1
Sell
-12
Closed 725
2020
Q4
$0 Hold
12
﹤0.01% 803
2020
Q3
$0 Hold
12
﹤0.01% 616
2020
Q2
$0 Hold
12
﹤0.01% 662
2020
Q1
$0 Hold
12
﹤0.01% 719
2019
Q4
$0 Hold
12
﹤0.01% 727
2019
Q3
$0 Hold
12
﹤0.01% 741
2019
Q2
$0 Hold
12
﹤0.01% 773
2019
Q1
$0 Hold
12
﹤0.01% 773
2018
Q4
$0 Hold
12
﹤0.01% 734
2018
Q3
$0 Buy
+12
New +$317 ﹤0.01% 682
2017
Q4
Sell
-2
Closed 886
2017
Q3
$0 Buy
+2
New +$63 ﹤0.01% 915

Other funds holding XRX

Loring Wolcott & Coolidge Fiduciary Advisors's XRX Position: Q1 2024 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Xerox (XRX) in Q1 2024, closing a stake of 12 shares — an estimated $222 sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in XRX in Q3 2017 and held it in 22 quarters. The position peaked at $15K in Q4 2021. 335 funds tracked by Wall St. Rank hold XRX as of Q1 2024.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Xerox position as of Q1 2024 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 12 Xerox shares in Q1 2024, an estimated $222.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Xerox in Q3 2017 and held it in 22 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Xerox position peaked at $15K in Q4 2021.
  • 335 funds tracked by Wall St. Rank held Xerox as of Q1 2024.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.